GHSI - Guardion Health Sciences Book Valuation of Business

Guardion Health Science (GHSI) generates revenue through the sale of Lumega-Z specialized nutrition and supplements for individuals with retinal damage. The team leverages the expertise of ophthalmologists and nutritionists to develop an evidence-based approach to formulation. The current metric stands at 0.01, however, a capital deficit driven by R&D expenditures is forcing the company to seek investment. This price chart clearly demonstrates the consequences of this financial pressure.

GHSI Guardion Health Book Capitalization (07/04/2022 - 10/19/2024)

Metric breakdowns and analytics for Guardion Health Sciences (GHSI)

- price and consensus price forecast:

Market Chart Guardion Health|GHSI - Analyst Consensus Forecast

- market capitalization data:

Market Capitalization Guardion Health Sciences Inc.|GHSI - Total Company Value

- book capitalization data:

Share Book Value Guardion Health Sciences|GHSI - Book Capitalization|Market Value to Book Value guardionhealth.com|GHSI - Company Total Assets

- debt and liquidity data:

Total Debt to Capital Guardion Health Science|GHSI - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Guardion Health Sciences, Inc.|GHSI - Company Debts|Debt to Book Value Guardion Health Sciences Inc.

Fundamental valuation:GHSI - Guardion Health

Flagship merchandise of Guardion Health Sciences, Inc.

Book value capitalization reflects the net asset value of Guardion Health Sciences (GHSI) minus all liabilities, excluding market noise and leverage. By analyzing the book value capitalization trend of Guardion Health Sciences, an investor assesses the intrinsic resilience of the business, which is supported at Guardion Health Sciences by a highly specialized staff of ophthalmology product experts and a stable commercial strategy within a high-margin niche.

Competitor analysis for Guardion Health Science